Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 194

The DOI matches its Crossref record.

Consensus guidelines on plasma cell myeloma minimal residual disease analysis and reporting

Open access
Arroz, Maria, Came, Neil, Lin, Pei, Chen, Weina, Yuan, Constance, Lagoo, Anand, Monreal, Mariela, de Tute, Ruth, Vergilio, Jo‐Anne, Rawstron, Andy C., Paiva, Bruno·2016·Cytometry Part B: Clinical Cytometry

Abstract

Background: Major heterogeneity between laboratories in flow cytometry (FC) minimal residual disease (MRD) testing in multiple myeloma (MM) must be overcome. Cytometry societies such as the International Clinical Cytometry Society and the European Society for Clinical Cell Analysis recognize a strong need to establish minimally acceptable requirements and recommendations to perform such complex testing. Methods: A group of 11 flow cytometrists currently performing FC testing in MM using different instrumentation, panel designs (≥ 6‐color) and analysis software compared the procedures between their respective laboratories and reviewed the literature to propose a consensus guideline on flow‐MRD analysis and reporting in MM. Results/Conclusion: Consensus guidelines support i) the use of minimum of five initial gating parameters (CD38, CD138, CD45, forward, and sideward light scatter) within the same aliquot for accurate identification of the total plasma cell compartment; ii) the analysis of potentially aberrant phenotypic markers and to report the antigen expression pattern on neoplastic plasma cells as being reduced, normal or increased, when compared to a normal reference plasma cell immunophenotype (obtained using the same instrument and parameters); and iii) the percentage of total bone marrow plasma cells plus the percentages of both normal and neoplastic plasma cells within the total bone marrow plasma cell compartment, and over total bone marrow cells. Consensus guidelines on minimal current and future MRD analyses should target a lower limit of detection of 0.001%, and ideally a limit of quantification of 0.001%, which requires at least 3 × 10 6 and 5 × 10 6 bone marrow cells to be measured, respectively. © 2015 International Clinical Cytometry Society

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/cyto.b.21228

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 194

Metadata

Authors
Arroz, M., Came, N., Lin, P., Chen, W., Yuan, C., Lagoo, A., Monreal, M., de Tute, R., Vergilio, J., Rawstron, A. C., & Paiva, B.
Venue
Cytometry Part B: Clinical Cytometry
Publisher
Wiley
Published
2015-06-02
Volume
90
Issue
1
Pages
31-39
ISSN
  • 1552-4949 (ISSN-L)
  • 1552-4957
OpenAlex
W1918445149
Cited by
194
References
0
FWCI
10.63
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Consensus guidelines on plasma cell myeloma minimal residual disease analysis and reporting. https://app.cochat.ai/papers/10.1002/cyto.b.21228
The paper
Arroz, M., Came, N., Lin, P., Chen, W., Yuan, C., Lagoo, A., Monreal, M., de Tute, R., Vergilio, J., Rawstron, A. C., & Paiva, B. (2016). Consensus guidelines on plasma cell myeloma minimal residual disease analysis and reporting. Cytometry Part B: Clinical Cytometry. https://doi.org/10.1002/cyto.b.21228

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.